{"id":"W2032490154","doi":"10.2174/157488406778249325","title":"Sorafenib (BAY 43-9006): Review of Clinical Development","year":2006,"lang":"en","type":"review","venue":"Current Clinical Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Rash; Pharmacology; Tyrosine-kinase inhibitor; Renal cell carcinoma; Internal medicine; Platelet-derived growth factor receptor; Oncology; Toxicity; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007571364,0.0008953222,0.001514747,0.002043338,0.0002310366,0.001056816,0.001219126,0.0008479943,0.005262871],"category_scores_gemma":[0.0006768894,0.0003460755,0.0004201076,0.002439671,0.0004125627,0.001502713,0.0005687591,0.001497586,0.003805783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006362658,"about_ca_system_score_gemma":0.000971664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007427906,"about_ca_topic_score_gemma":0.001827277,"domain_scores_codex":[0.9998393,0.00002445127,0.0000245304,0.0000321803,0.00006313885,0.00001631954],"domain_scores_gemma":[0.9997166,0.00008139683,0.00004607398,0.00000899489,0.00008708454,0.00005980281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000156449,0.0001123513,0.000126463,0.005234689,0.00004132535,0.0002024877,0.00002252538,0.0002798322,0.001556498,0.0009533799,0.02643582,0.9648781],"study_design_scores_gemma":[0.0001213924,0.0003267941,0.001029378,0.001853592,0.0001045449,0.001544491,0.00004241545,0.0001459625,0.0006323992,0.001013479,0.9931666,0.00001904947],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003077037,0.9976463,0.0002245999,0.0004155168,0.0002068543,0.00001015996,0.00003110671,0.00001884883,0.00113904],"genre_scores_gemma":[0.001114312,0.9969645,0.0004327505,0.0003014033,0.0001888182,0.00001171266,0.00007200216,0.000003079911,0.0009113639],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005262871,"threshold_uncertainty_score":0.01760608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2477982877687997,"score_gpt":0.5447069939674991,"score_spread":0.2969087061986994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}